MedPath

SAHAJANAND MEDICAL TECHNOLOGIES LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

CRUZ Tunisia-Multivessel Registry

Recruiting
Conditions
Patient Population With Multivessel Disease
First Posted Date
2024-10-29
Last Posted Date
2025-02-19
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
1000
Registration Number
NCT06663696
Locations
🇹🇳

Sahloul Hospital, Sousse, Tunisia

🇹🇳

Habib Thameur Hospital, Tunis, Tunisia

Hydra Registry - UK

Recruiting
Conditions
Aortic Valve Stenosis
Interventions
Device: Hydra transcatheter aortic valve (THV) series
First Posted Date
2024-07-18
Last Posted Date
2025-02-19
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
250
Registration Number
NCT06507579
Locations
🇬🇧

Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, Yorkshire, United Kingdom

🇬🇧

Royal Victoria Hospital, Belfast, United Kingdom

🇬🇧

Royal Papworth, Cambridge, United Kingdom

and more 1 locations

Hydra Single-centre Experience - Copenhagen, Denmark

Recruiting
Conditions
Aortic Valve Stenosis
First Posted Date
2024-04-02
Last Posted Date
2024-07-05
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
50
Registration Number
NCT06342635
Locations
🇩🇰

Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Hydra Registry - Italy Experience

Recruiting
Conditions
Aortic Valve Stenosis
First Posted Date
2023-07-21
Last Posted Date
2025-05-16
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
500
Registration Number
NCT05956652
Locations
🇮🇹

Fondazione Poliambulanza Istituto, Brescia, Italy

🇮🇹

Montevergine Clinic, Mercogliano, Italy, Mercogliano, Italy

🇮🇹

IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milano, Italy

and more 1 locations

Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent

Completed
Conditions
Coronary Artery Disease
Interventions
Device: Supraflex Cruz Sirolimus-eluting Stent
First Posted Date
2019-10-24
Last Posted Date
2023-07-12
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
1200
Registration Number
NCT04138238
Locations
🇫🇷

Hôpital Privé Claude Galien, Quincy-sous-Sénart, France

🇫🇷

Hôpital Privé Jacques Cartier, Massy, France

🇩🇪

Kerckhoff Heart Center, Bad Nauheim, Germany

and more 23 locations

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

Recruiting
Conditions
Coronary Artery Disease
First Posted Date
2018-02-23
Last Posted Date
2024-07-05
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
7000
Registration Number
NCT03443999
Locations
🇳🇱

Medical Center Leeuwarden, Leeuwarden, Friesland, Netherlands

🇳🇱

ZorgSaam Hospital, Terneuzen, Zeeuws- Vlaanderen, Netherlands

🇳🇱

Tergooi Ziekenhuis, Blaricum, North Holland, Netherlands

and more 4 locations

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Phase 4
Completed
Conditions
Coronary Artery Disease
Interventions
Device: Supralimus® Sirolimus-Eluting Coronary Stent
First Posted Date
2011-06-08
Last Posted Date
2012-08-23
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
1274
Registration Number
NCT01368627
Locations
🇧🇷

CIAS- Unimed Vitória, Vitória, Espírito Santo, Brazil

🇧🇷

H.C.Unesp, Botucatu, Sao Paulo, Brazil

🇧🇷

Hospital Monte Sinai, Juiz de Fora, Minas Gerais, Brazil

and more 4 locations

Supralimus-Core™ Pharmacokinetic (PK) Study

Not Applicable
Completed
Conditions
Coronary Artery Disease
First Posted Date
2010-05-12
Last Posted Date
2012-07-04
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
20
Registration Number
NCT01121744
Locations
🇮🇳

Baroda Heart Institute & Research Center, Baroda, Gujarat, India

🇮🇳

Shree B. D. Mahavir Heart Institute, Surat, Gujarat, India

🇮🇳

Life Care Institute of Medical Science & research, Ahmedabad, Gujarat, India

and more 1 locations

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Phase 4
Terminated
Conditions
Coronary Artery Disease
Interventions
Device: Infinnium-Core™ Paclitaxel eluting Coronary Stent
First Posted Date
2009-07-10
Last Posted Date
2012-08-23
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
67
Registration Number
NCT00936780
Locations
🇮🇳

CHL Apollo Hospitals,, Indore., Madhya Pradesh., India

🇮🇳

Baroda Heart Institute & Research Center, Vadodara, Gujarat, India

🇮🇳

Sri Ramakrishna Heart Foundation & Research Centre, Coimbatore, Tamilnadu, India

and more 4 locations

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Phase 4
Terminated
Conditions
Coronary Artery Disease
Interventions
Device: Supralimus(R) Sirolimus-Eluting Coronary Stent System
Device: Xience V™ Everolimus Eluting Coronary Stent
First Posted Date
2009-06-10
Last Posted Date
2012-08-23
Lead Sponsor
Sahajanand Medical Technologies Limited
Target Recruit Count
13
Registration Number
NCT00917163
Locations
🇮🇳

All India Institute of Medical Sciences, New Delhi, Delhi, India

🇮🇳

Escorts Heart Institute & Research Centre, New Delhi, Delhi, India

🇮🇳

Max Devki Devi Heart and Vascular Institute, New Delhi, Delhi, India

and more 24 locations
© Copyright 2025. All Rights Reserved by MedPath